13.4 ML hyaluronidase, human recombinant 2000 UNT/ML / rituximab 120 MG/ML Injection
RxNorm concept 1927893, clinical drug (scd). Prescribable name: riTUXimab 1600 MG / hyaluronidase, human recombinant 26,800 UNT in 13.4 mL Injection.
- RxCUI
- 1927893
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1927893 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
13.4 ML hyaluronidase, human recombinant 2000 UNT/ML / riTUXimab 120 MG/ML Injection; riTUXimab 1600 MG / hyaluronidase, human recombinant 26,800 UNT per 13.4 ML Injection; rituximab 1600 MG / hyaluronidase, human recombinant 26,800 UNT per 13.4 ML Injection
Related concepts
- hyaluronidase, human recombinant 2000 UNT/ML (SCDC, consists of)
- rituximab 120 MG/ML (SCDC, consists of)
- Injection (DF, has dose form)
- 13.4 ML hyaluronidase, human recombinant 2000 UNT/ML / rituximab 120 MG/ML Injection [Rituxan Hycela] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1927893 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1927893 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1927893. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.